GlassScriptPhysician profile
Stephen C Wenzke
NPI 1982603379
$745.75
in general payments reported to CMS, 2019-2025
11 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2023: $139 · 2024: $229 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $143.43 | 2019-2024 | Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $91.59 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.81 | 2023-2025 | Jardiance |
| Amgen INC. | $81.32 | 2023-2025 | Repatha, Repatha |
| Fresenius USA Marketing, INC. | $75.25 | 2023 | Velphoro |
| Boston Scientific Corporation | $66.25 | 2024-2025 | Watchman Flx |
| Merck Sharp & Dohme LLC | $60.31 | 2023-2025 | Verquvo, Winrevair |
| E.R. Squibb & Sons, L.L.C. | $59.05 | 2024-2025 | Camzyos, Eliquis |
| Pfizer INC. | $30.75 | 2023-2025 | |
| Medtronic Vascular, INC. | $28.74 | 2019 | |
| Alnylam Pharmaceuticals INC. | $22.25 | 2025 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Wenzke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.